Avantor, Inc.
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials…
Chemicals - Specialty
US, Radnor [HQ]
AVTR/Financial Reporting
Income Statements
9 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2001 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 691.00 | 1,247.00 | 5,864.00 | 6,040.00 | 6,393.00 | 7,386.00 | 4,909.00 | 7,512.00 | 6,967.00 | |
|
EPS
|
-0.09 | -0.23 | -0.18 | -0.84 | 0.20 | 0.86 | 1.05 | 1.02 | 0.48 | |
| Diluted in mil. | -0.09 | -0.23 | -0.18 | -0.84 | 0.20 | 0.85 | 1.01 | 1.01 | 0.47 | |
|
Profit
|
319.00 | 432.00 | 1,819.00 | 1,920.00 | 2,080.00 | 2,502.00 | 2,602.00 | 2,602.00 | 2,363.00 | |
| Gross Margin | 46.25 | 34.70 | 31.03 | 31.80 | 32.54 | 33.88 | 53.01 | 34.65 | 33.93 | |
| Pre Tax | -70.00 | -460.00 | -113.00 | 40.00 | 62.00 | 753.00 | 851.00 | 851.00 | 410.00 | |
| Profit Margin | -10.21 | -36.89 | -1.94 | 0.67 | 0.97 | 10.19 | 17.34 | 11.33 | 5.89 | |
| ETR | -14.31 | 68.43 | 23.64 | 6.90 | -87.16 | 23.96 | -19.34 | 19.34 | 21.78 | |
| Net | -42.00 | -112.00 | -86.00 | 37.00 | 116.00 | 572.00 | 686.00 | 686.00 | 321.00 | |
| Profit Margin | -6.13 | -9.03 | -1.48 | 0.63 | 1.82 | 7.75 | 13.98 | 9.14 | 4.61 | |
| EBITDA | 70.00 | -107.00 | 821.00 | 953.00 | 1,112.00 | 1,362.00 | 1,130.00 | 1,534.00 | 1,262.00 | |
| EBITDA Margin | 10.18 | -8.64 | 14.00 | 15.78 | 17.39 | 18.44 | 23.02 | 20.43 | 18.12 | |
| Operating Income | 9.00 | -210.00 | 413.00 | 551.00 | 706.00 | 972.00 | 1,130.00 | 1,130.00 | 696.00 | |
| Operating Margin | 1.43 | -16.87 | 7.05 | 9.14 | 11.05 | 13.16 | 23.02 | 15.04 | 10.00 | |
| Interest Income | - - | - - | - - | 440.00 | 307.00 | 229.00 | - - | 265.00 | - - | |
| Loss | -681.00 | -1,457.00 | -5,450.00 | -5,488.00 | -5,686.00 | -6,413.00 | -3,779.00 | -6,382.00 | -6,110.00 | |
| Cost of Revenue | -371.00 | -814.00 | -4,044.00 | -4,119.00 | -4,313.00 | -4,883.00 | -2,306.00 | -4,909.00 | -4,603.00 | |
|
Operating Expenses
|
-309.00 | -643.00 | -1,406.00 | -1,368.00 | -1,373.00 | -1,530.00 | -1,472.00 | -1,472.00 | -1,506.00 | |
| R&D | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| G&A | -309.00 | -643.00 | -1,406.00 | -1,368.00 | -1,373.00 | - - | - - | - - | - - | |
| SG&A | -309.00 | -643.00 | -1,406.00 | -1,368.00 | -1,373.00 | -1,530.00 | -1,472.00 | -1,472.00 | -1,506.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Depreciation and Amortization | -60.00 | -99.00 | -404.00 | -398.00 | -395.00 | -379.00 | -405.00 | -405.00 | -402.00 | |
| Interest Expenses | -80.00 | -200.00 | -523.00 | -440.00 | -307.00 | -217.00 | -265.00 | -265.00 | -284.00 | |
| Other Expenses | - - | -48.00 | -3.00 | -511.00 | -644.00 | -219.00 | -279.00 | -279.00 | -161.00 | |
|
WA Shares Outstanding
|
491.00 | 496.00 | 496.00 | 401.00 | 576.00 | 590.00 | 650.00 | 650.00 | 675.00 | |
| Diluted | 491.00 | 496.00 | 496.00 | 401.00 | 583.00 | 599.00 | 679.00 | 679.00 | 678.00 |